oligomer
procyanidin
opc
shown
antivir
immunostimulatori
effect
opc
isol
nonrip
appl
peel
test
capac
reduc
dengu
viru
denv
titer
similar
publish
account
opc
exhibit
direct
antivir
activ
possibl
enhanc
innat
immun
protect
also
test
measur
character
gene
protein
express
induc
opc
denv
infect
treatment
denvinfect
human
pbmc
opc
decreas
viral
titer
affect
express
critic
innat
antivir
immun
product
opc
enhanc
express
mxi
ifnb
transcript
high
moi
denv
infect
pbmc
cultur
phosphoryl
respons
recombin
type
ifn
ifn
low
moi
infect
addit
opc
increas
express
transcript
mhc
protein
product
thu
opc
exhibit
innat
immun
stimul
cell
denvinfect
cultur
uninfect
cell
treat
ifn
opc
number
sourc
known
exhibit
antivir
effect
mechan
precis
defin
capac
opc
increas
sensit
ifn
could
broadli
applic
mani
viral
infect
two
separ
antivir
mechan
suggest
opc
may
repres
novel
robust
antivir
therapi
dengu
viru
denv
niaid
categori
pathogen
denv
infect
repres
one
import
emerg
threat
human
health
worldwid
past
year
infect
rate
dramat
increas
part
due
popul
urban
four
relat
virus
differ
serotyp
transmit
mosquito
caus
denv
infect
vaccin
develop
complic
difficulti
develop
small
anim
model
relev
human
diseas
well
phenomenon
antibodydepend
enhanc
ade
ade
involv
antibodi
specif
one
denv
serotyp
may
neutral
denv
serotyp
rather
nonneutr
cross
reactiv
antibodi
enhanc
diseas
sever
upon
secondari
infect
differ
serotyp
halstead
orourk
virtual
antivir
treatment
denv
mosquito
control
measur
larg
fail
curb
denv
incid
part
world
necessit
novel
approach
protect
primari
cellular
target
denv
infect
human
monocytemacrophag
chunhakan
et
al
kou
et
al
although
detail
denv
infect
complet
understood
earli
innat
respons
appear
critic
direct
subsequ
infect
either
selflimit
dengu
fever
sever
potenti
lethal
dengu
hemorrhag
fever
chen
et
al
shresta
et
al
mani
viral
infect
type
ifn
ifn
respons
critic
denv
protect
exemplifi
commonli
use
mous
model
util
ifn
receptordefici
mice
shresta
et
al
polyphenol
larg
divers
group
aromaticrich
plant
metabolit
identifi
number
food
sourc
dietari
supplement
cranberri
juic
grape
seed
pomegran
unrip
appl
peel
holder
et
al
terra
et
al
larg
oligomer
procyanidin
opc
bind
precipit
basic
prolinerich
protein
foundin
saliva
charlton
et
al
holder
et
al
antivir
effect
mani
differ
type
polyphenol
includ
monomer
hydrolys
tannin
describ
haidari
et
al
greater
evid
suggest
robust
antivir
activ
contain
larger
order
oligomer
fraction
opc
also
refer
condens
tannin
oligomer
proanthocyanidin
feng
et
al
hauber
et
al
su
et
al
takeshita
et
al
zhuang
et
al
exampl
larges
opc
blueberri
leav
block
replic
hepat
c
viru
hcv
rna
subgenom
replicon
express
system
takeshita
et
al
addit
procyanidinrich
extract
french
maritim
pine
block
intracellular
replic
bind
host
cell
although
precis
mechan
discov
feng
et
al
although
direct
antivir
interact
opc
viru
demonstr
varieti
viral
agent
descript
precis
effect
larg
limit
block
earli
step
viral
entri
cell
line
necessarili
relev
natur
infect
vivo
recent
identifi
opc
deriv
unrip
appl
peel
found
dietari
supplement
applepoli
stimulatori
innat
lymphocyt
respons
specif
oligomer
monomer
procyanidin
indic
uniqu
nonantioxid
respons
holder
et
al
holder
et
al
hypothes
opc
would
also
demonstr
antivir
effect
potenti
test
denv
infect
human
pbmc
addit
opc
denvinfect
cell
consist
decreas
viral
titer
vitro
expect
effect
due
part
reduct
infecti
titer
direct
interact
opc
denv
potenti
enhanc
innat
respons
viru
infect
presenc
opc
also
character
result
indic
opc
enhanc
innat
immun
respons
denv
infect
part
alter
express
gene
protein
typei
ifn
ifn
pathway
high
moi
infect
addit
opc
appear
circumv
denvspecif
mechan
block
pathway
opc
also
enhanc
phosphoryl
respons
recombin
ifn
affect
cell
low
moi
infect
cultur
increas
express
transcript
mhc
protein
thu
opc
induc
innat
antivir
respons
may
broadli
applic
viral
infect
knowledg
studi
first
identifi
stimul
critic
antivir
innat
respons
opc
target
cell
highli
relev
viral
infect
vivo
strain
obtain
dr
robert
tesh
world
refer
center
emerg
virus
arbovirus
utmb
wrceva
grown
high
titer
cell
atcc
viru
concentr
ultracentrifug
hour
denv
quantifi
use
adapt
endpoint
titrat
assay
cell
atcc
sextuplet
well
plate
briefli
denvinfect
infect
human
pbmc
cultur
supernat
monomer
oligomer
procyanidin
vehicl
ad
concentr
viru
stock
serial
dilut
mem
sextuplet
well
plate
lowpassag
cell
ad
well
complet
mem
serum
penicillinstreptomycin
cmem
well
supplement
cmem
hour
assay
set
assay
termin
day
incub
co
addit
crystal
violet
methanol
well
viru
quantifi
tcid
ml
analys
pattern
cytopath
effect
cpe
adapt
sextuplet
well
accord
method
reed
muench
reed
muench
monomer
procyanidin
opc
appli
cell
ml
effect
cell
viabil
direct
interact
opc
denv
assess
incub
denv
mem
vari
concentr
monomer
procyanidin
opc
hour
mixtur
appli
endpoint
titrat
assay
human
subject
volunt
depart
volunt
serolog
test
dengu
antibodi
test
found
neg
dengu
antibodi
importantli
studi
pbmc
separ
sera
thu
would
eventu
interest
ade
test
assay
human
pbmc
collect
previous
describ
holder
et
al
approxim
blood
collect
per
subject
whole
blood
dilut
hank
buffer
underlaid
histopaqu
sigma
ml
tube
tube
centrifug
minut
result
buffi
layer
contain
pbmc
aspir
cell
wash
hank
buffer
centrifug
minut
rbc
remov
water
lysi
addit
wash
isol
cell
infect
moi
defin
tcid
cell
indic
depend
experi
minim
volum
hour
unattach
viru
wash
ad
media
centrifug
lonza
walkersvil
inc
serumfre
media
ad
cell
result
cellsml
crude
extract
applepoli
put
trimer
tetram
procyanidin
isol
applepoli
normal
phase
hplc
previous
describ
holder
et
al
monomer
procyanidin
catechin
fisher
epicatechin
sigma
also
vehicl
ad
tissu
cultur
media
potenti
toxic
contamin
microbi
pattern
crude
appl
peel
extract
opc
fraction
address
previous
holder
et
al
neither
contamin
lp
innat
agonist
advers
effect
human
cell
concentr
detect
holder
et
al
holder
et
al
cell
cultur
hour
supernat
fluid
cell
collect
supernat
fluid
use
measur
denv
titer
endpoint
titrat
assay
well
elisa
biolegend
denv
detect
hour
infect
seroneg
donor
sampl
exclud
analys
rna
extract
minimum
adher
cell
gene
express
pattern
analyz
qpcr
previous
describ
hedg
et
al
assess
phosphoryl
human
pbmc
respons
opc
ifn
human
pbmc
collect
stimul
opc
vehicl
hour
recombin
univers
ifn
pbl
interferon
sourc
vehicl
ad
cell
minut
prior
collect
cell
pellet
cell
per
treatment
storag
cell
pellet
lyse
mper
pierc
halt
proteas
phosphatas
inhibitor
pierc
per
manufactur
suggest
ice
minut
lysat
centrifug
minut
laemmli
sampl
buffer
ad
lysat
supernat
fluid
sampl
boil
minut
load
onto
prepar
gel
run
volt
protein
transfer
pvdf
volt
hour
blot
block
bsa
tbst
hour
rt
primari
antibodi
santa
cruz
biotech
dilut
bsa
tbst
incub
overnight
rock
blot
wash
secondari
antibodi
goat
antirabbit
igghrp
dilut
bsa
tbst
ad
incub
hour
rt
rock
blot
wash
ad
novex
ecl
invitrogen
expos
radiographi
film
process
immedi
blot
strip
use
mild
strip
buffer
glycin
sd
tween
ph
incub
minut
two
time
wash
twice
pb
twice
tbst
confirm
uniform
protein
load
number
cell
per
pellet
alway
use
blot
block
incub
overnight
antigapdh
antibodi
santa
cruz
biotech
dilut
bsa
tbst
blot
process
develop
describ
densitometri
calcul
use
imagej
nih
softwar
band
region
normal
lane
background
human
pbmc
donor
collect
either
uninfect
treat
recombin
univers
ifn
pbl
interferonsourc
infect
denv
moi
treat
either
trimer
opc
vehicl
hour
cell
collect
gentl
scrape
stain
antibodi
specif
conjug
pe
bd
phamingen
hlaa
b
c
conjug
apc
clone
biolegend
conjug
pe
clone
bd
phamingen
cell
wash
pb
hors
serum
read
bd
facscalibur
flow
cytomet
statist
signific
calcul
comparison
data
deriv
use
human
pbmc
wilcoxon
sign
rank
test
pair
data
prism
graphpad
inc
unless
otherwis
note
otherwis
signific
calcul
use
student
pair
test
opc
innat
immunomodulatori
activ
graff
jutila
holder
et
al
test
abil
reduc
denv
titer
infect
human
pbmc
vitro
low
high
moi
infect
crude
extract
opc
deriv
unrip
appl
peel
consist
decreas
denv
titer
figur
capac
denv
replic
vari
human
subject
even
infect
moi
averag
reduct
denv
titer
crude
opc
extract
previous
identifi
oligomer
monomer
opc
activ
fraction
extract
applepoli
holder
et
al
similarli
commerci
monomer
form
opc
epicatechin
catechin
consist
reduc
denv
titer
fig
concentr
put
trimer
opc
purifi
applepoli
extract
holder
et
al
effect
reduct
denv
titer
crude
extract
figur
case
averag
reduct
denv
titer
upon
addit
opc
highli
signific
observ
infect
cell
human
subject
test
despit
substanti
genet
experienti
variat
subject
suggest
opc
may
repres
robust
antivir
treatment
opc
bind
protein
charlton
et
al
direct
interact
opc
viru
appear
common
mechan
reduc
viru
titer
feng
et
al
hauber
et
al
su
et
al
zhuang
et
al
possibl
import
interact
test
found
system
oligomer
form
trimer
tetram
procyanidin
directli
block
denv
infect
result
reduc
titer
similar
concentr
monomer
procyanidin
catechin
littl
effect
data
shown
experi
conduct
determin
reduct
viral
titer
confer
opc
could
also
result
innat
immun
enhanc
infect
human
monocyt
macrophag
denv
known
interfer
sensit
ifn
pathway
ashour
et
al
mazzon
et
al
rodriguezmadoz
et
al
rodriguezmadoz
et
al
thu
gene
transcript
relev
pathway
measur
human
pbmc
cell
infect
denv
high
moi
uninfect
cell
cell
treat
opc
denvinfect
opctreateddenvinfect
cell
compar
hour
cultur
result
figur
c
suggest
opc
alon
littl
effect
transcript
express
addit
opc
denv
infect
alter
mrna
content
ifnb
express
induc
cell
sens
viral
rna
block
denv
infect
rodriguezmadoz
et
al
human
cell
denv
establish
infect
least
part
also
attenu
ifn
signal
via
inhibit
phosphoryl
ashour
et
al
mazzon
et
al
key
antivir
product
induc
phosphoryl
phosphoryl
follow
signal
ifn
sinc
denv
block
phosphoryl
express
unchang
denvinfect
cell
mazzon
et
al
consist
account
signific
chang
ifnb
transcript
level
detect
whether
cell
uninfect
treat
opc
denvinfect
contrast
ifnb
significantli
increas
opctreateddenvinfect
cell
averag
respect
cell
infect
denv
fig
induct
gene
respons
opc
like
relat
sinc
turn
induc
express
data
suggest
addit
opc
stimul
antivir
innat
immun
respons
appear
revers
viral
inhibit
transcript
gene
ifn
pathway
gene
relat
ifn
pathway
also
measur
surprisingli
transcript
encod
induc
denv
infect
ip
liao
induc
low
amount
ifn
pattern
ofexpress
opposit
ifnb
respons
opc
denv
infect
increas
express
addit
opc
infect
cell
dramat
reduc
express
averag
respect
compar
denv
infect
alon
figur
gene
express
chang
induc
opc
denv
infect
statist
signific
despit
substanti
genet
experienti
differ
human
donor
subject
evid
figur
substanti
differ
clearli
demonstr
transcript
gene
follow
express
pattern
similar
respons
denv
express
mazzon
et
al
contrast
clear
pattern
express
respons
opc
treatment
human
pbmc
note
rather
express
appear
specif
donor
subject
interestingli
specif
mutat
human
account
increas
suscept
west
nile
viru
infect
lim
et
al
despit
differ
subject
addit
opc
denvinfect
human
pbmc
oppos
effect
gene
express
compar
denv
infect
alon
sever
differ
gene
result
suggest
partial
rescu
denvmedi
alter
gene
express
opc
treatment
discov
impact
opc
ifn
signal
pathway
absenc
viral
interfer
perform
experi
determin
opc
enhanc
respons
ifn
human
pbmc
incub
opc
vehicl
hour
recombin
ifn
ad
cell
collect
minut
analysi
phosphoryl
western
blot
condit
use
phosphoryl
ifn
alon
faintli
detect
howev
cell
everi
donor
donor
sampl
treat
opc
ifn
distinct
band
indic
phosphoryl
respons
ifn
stronger
opctreat
cell
fig
induct
enhanc
respons
ifn
byopc
may
relev
mani
viral
challeng
data
suggest
addit
opc
might
induc
chang
gene
express
denvinfect
bystand
cell
infect
cultur
sinc
opc
improv
ifn
signal
respons
sought
measur
ifn
respons
bystand
cell
low
moi
denv
infect
approach
allow
neighbor
uninfect
cell
respond
ifn
cytokin
produc
infect
cell
therefor
predict
vivo
infect
high
moiinfect
cultur
alter
gene
express
opc
uninfect
bystand
cell
present
low
moi
denvinfect
cultur
test
low
moi
low
express
level
consist
chang
transcript
ifnb
data
shown
suggest
transcript
gene
consist
chang
opctreat
high
moi
denvinfect
cultur
howev
wherea
high
moiinfect
opctreat
cultur
express
decreas
uninfect
cell
repres
low
moi
infect
consist
increas
transcript
express
opc
treatment
averag
increas
figur
express
induc
low
concentr
ifn
signal
prime
cell
innat
respons
stimul
also
critic
protect
denv
infect
gough
et
al
shresta
et
al
result
indic
opc
improv
ifn
signal
capac
infect
cell
andor
ifn
respons
bystand
cell
denv
infect
potenti
downstream
consequ
increas
sensit
ifn
signal
test
chang
express
mhc
measur
uninfect
recombin
ifn
treat
low
moi
denvinfect
cell
treat
trimer
opc
mean
fluoresc
intens
mfi
mhc
significantli
increas
treatment
ifn
denv
infect
alon
compar
untreat
cell
fig
treatment
addit
opc
increas
mhc
express
wherea
differ
opctreat
uninfect
ifntreat
cell
opctreateddenvinfect
cultur
larger
increas
mhc
express
suggest
increas
respons
denv
induc
cytokin
ifn
cultur
mhci
express
pattern
unimod
indic
shift
express
occur
cell
regardless
viru
infect
figur
express
follow
gener
trend
variat
donor
subject
preclud
signific
differ
data
shown
opcinduc
increas
mhc
present
peptid
antigen
cell
costimulatori
molecul
monocytemacrophag
suggest
opc
may
also
enhanc
downstream
adapt
immun
respons
result
suggest
presenc
opc
bystand
cell
may
better
respond
denv
infect
initi
antivir
protocol
better
protect
infect
import
inflammatori
cytokin
denv
pathogenesi
progress
sever
hemorrhag
form
diseas
chen
et
al
devignot
et
al
determin
effect
opc
product
denv
infect
measur
protein
content
supernat
fluid
uninfect
opctreat
denvinfect
treateddenvinfect
human
pbmc
low
high
moi
infect
protein
express
pattern
consist
observ
express
transcript
name
high
moi
denv
infect
express
highli
induc
consist
publish
report
chen
et
al
nightingal
et
al
addit
opc
appear
decreas
express
denvinfect
cell
contrast
low
moi
denv
infect
alon
consist
alter
detect
cultur
supernat
addit
opc
caus
signific
increas
express
presum
larg
bystand
cell
data
suggest
addit
opc
affect
sever
aspect
innat
immun
respons
viral
infect
data
suggest
addit
direct
antivir
effect
opc
deriv
applepoli
enhanc
antivir
innat
immun
figur
highmoi
denv
infect
viral
mechan
block
product
respons
ifn
infect
cell
ashour
et
al
mazzon
et
al
rodriguezmadoz
et
al
denv
infect
increas
presum
express
increas
express
hober
et
al
nightingal
et
al
wati
et
al
data
figur
consist
respons
also
suggest
slight
increas
express
respons
low
ifn
denv
infect
cell
gough
et
al
addit
opc
highmoi
infect
appear
revers
viral
mechan
result
increas
transcript
ifnb
mxi
decreas
reduct
figur
top
panel
lowmoi
infect
smaller
minor
cell
infect
denv
respons
uninfect
bystand
cell
predomin
state
like
relev
initi
infect
vivo
cytokin
express
infect
cell
promot
local
antivir
respons
part
model
low
ifn
supplement
upon
addit
opc
low
moi
infect
increas
mhc
note
figur
lower
panel
data
suggest
addit
opc
result
intensifi
innat
antivir
state
warrant
studi
vivo
denvinfect
cell
increas
product
may
eventu
contribut
advers
patholog
denv
hemorrhag
diseas
chen
et
al
hober
et
al
hober
et
al
howev
may
also
benefici
earli
innat
immun
protect
exampl
treatment
denvinfect
monocyt
alter
infect
preinfect
supplement
consist
decreas
infect
wati
etal
thu
opcinduc
express
bystand
cell
may
benefici
limit
denv
infect
wherea
opc
deriv
cocoa
shown
stimul
express
mao
et
al
addit
applederiv
trimer
opc
denvinfect
cell
high
moi
infect
decreas
overt
express
consid
advers
effect
excess
denv
hemorrhag
diseas
mani
inflammatori
condit
opc
supplement
may
provid
benefit
consid
global
challeng
denv
infect
multipl
viral
threat
treatment
option
dietari
supplement
could
substanti
benefit
exampl
recombin
ifn
use
therapi
hcv
infect
sinc
applepoli
safe
ingest
reach
relev
concentr
serum
ingest
holder
et
al
shoji
et
al
opc
block
hcv
replic
takeshita
et
al
may
render
human
cell
respons
ifn
figur
use
dietari
supplement
viral
infect
combin
ifn
treatment
hcv
patient
may
warrant
opc
applepoli
demonstr
direct
viral
interact
block
infect
enhanc
sever
differ
aspect
innat
antivir
immun
antivir
treatment
singl
defin
mechan
action
singlestrand
rna
virus
use
part
combin
therapi
high
likelihood
virus
rapidli
evolv
resist
valinotto
et
al
viral
therapeut
two
distinct
mechan
antivir
action
opc
like
reduc
risk
evas
highli
mutabl
virus
data
suggest
dietari
supplement
contain
high
concentr
opc
applepoli
may
enhanc
antivir
innat
immun
benefit
patient
face
viral
challeng
opc
deriv
applepoli
consist
decreas
denv
titer
upon
addit
infect
human
pbmc
denvinfect
human
pbmc
differ
human
subject
repres
differ
line
open
circl
denot
moi
close
circl
denot
moi
addit
crude
extract
applepoli
consist
result
lower
titer
measur
endpoint
titrat
b
put
trimer
opc
purifi
applepoli
slightli
effect
consist
crude
extract
reduc
titer
denvinfect
human
pbmc
c
shown
viral
system
monomer
procyanidin
catechin
epicatechin
minim
inconsist
effect
viral
titer
assay
addit
opc
high
moi
denvinfect
human
pbmc
affect
gene
express
ifn
signal
pathway
transcript
encod
ifnb
remain
unchang
cell
subject
uninfect
opctreat
denvinfect
cell
increas
upon
addit
opc
denvinfect
cultur
signific
calcul
use
student
pair
ttest
p
b
express
consist
reduc
presenc
opc
denv
infect
p
transcript
express
respons
denvinfect
opc
addit
consist
human
donor
e
phosphoryl
bare
detect
ifn
onlytr
cell
consist
clearli
detect
opcand
ifn
opc
alter
gene
protein
express
low
moi
denv
infect
stimul
ifn
opc
ad
low
moi
denv
infect
cell
express
increas
compar
vehicl
control
p
b
human
cell
donor
untreat
treat
low
rifn
infect
denv
stimul
opc
vehicl
express
mhc
hlaa
b
c
monocytemacrophag
measur
flow
cytometri
p
p
c
repres
histogram
one
donor
model
respons
cell
opc
circl
repres
cell
larger
font
boldfac
type
denot
intensifi
express
gene
cell
protein
cell
